63.21 % of retail investors lose their capital when trading CFDs with this provider.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63.21 % of retail investors lose their capital when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Moderna Stocks - price, description, and characteristics

A biotechnology business called Moderna, Inc. discovers, develops, and commercializes messenger RNA therapies and vaccines for the treatment of infectious illnesses, immuno-oncology, rare diseases, cardiovascular disorders, and autoimmune diseases in the United States, Europe, and other countries.

 

Vaccines developed by Moderna are divided into:

  • Respiratory (COVID-19, influenza, respiratory syncytial virus, endemic HCoV and hMPV+PIV3 vaccines)

  • Latent (cytomegalovirus, Epstein-Barr virus, human immunodeficiency virus, herpes simplex virus and varicella-zoster virus vaccines)

  • Public health vaccines (Zika and Nipah)


It has strategic partnerships with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, Carisma Therapeutics, Inc., Metagenomi, Inc., Defense Advanced Research Projects Agency, Biomedical Advanced Research and Development Authority, Institute for Life Changing Medicines, and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici.

Moderna company was originally known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Cambridge, Massachusetts serves as the corporate headquarters for Moderna, Inc., which was established in 2010.

Stéphane Bancel has been the Chief Executive Officer of Moderna since October 2011 and a member of the board of directors since March 2011. Moderna's President and Director of Research & Development is Stephen Hoge. For over ten years, Dr. Hoge has overseen Moderna's scientific endeavors.

Moderna stock performance

Given that Moderna is one of the industry's top suppliers of COVID-19 vaccines, its income stream soared in 2021. Moderna's stock has done much better than the overall market. Investor confidence in the company's COVID-19 vaccine helped the stock keep rising. Through the first half of summer 2021, in particular, its performance improved, but it has since given up some of those advantages.

The overall return on Moderna's shares has been 419.5%, which is much more than the 39.9% total return on the S&P 500. In the past, this has been the most lucrative time for Moderna. Since then, the market gains have leveled off and seem to be consistent.

The company has been in an uptrend since 2020 until the COVID-19 global pandemic hit, when the stock took off.

Moderna is one of the COVID-19 vaccine manufacturers, which we can see has reflected on the price as well, however, followed by a strong correction, the price sank back down to its pre-peak values.

The turbulent stock market has been also fueled by the Fed’s ultra-loose monetary policy, which we can see as spikes in the price chart.
 

Výkon akcií Moderna
 

Trade CFD stocks with Purple Trading

More than 100 stocks of the world’s most renowned companies in your MT4 platform; low spreads, and lightning-fast execution. That’s what trading CFD stocks with Purple Trading is all about.

Trading Moderna (MRNA) with Purple Trading

To start your Moderna CFDs trading, first, you need to locate the ticker MRNA on our Purple Trading MetaTrader 4 platform. To open a trade, either double-click or press the new order button, and the following window will pop up.

 

Akcie Moderna v platformě MT4
 

Lot value calculation

When you open our MetaTrader 4 platform and click on the MRNA ticker, you'll observe that the minimal volume for trading Moderna CFDs is one lot (1.0). If you trade one lot, you will gain or lose 10 USD for each 10 USD the stock makes as you are buying at a 1:1 ratio (1 lot equals 1 share). For example, you buy 5 lots at 140 USD, and Moderna goes to 150 USD. Your total profit will be 50 USD (calculated as 10 USD (1000 cents) movement * number of lots/shares per the move). The same logic applies to calculating your profit or loss when entering a short position.

Keep in mind that MRNA is quoted in US dollars, therefore if your account is in EUR or another currency, your profit or loss must be converted to EUR at the current exchange rate.

You can trade at the current market price (market execution) or utilize pending orders, (limit and stop orders). You can initiate the trade without the stop-loss and take-profit orders now and add them afterward.

Free ebook: How to trade CFD shares?

What do you find in the ebook?

  • A general explanation of the basic principles of CFD instruments

  • A description of the specifics and advantages of trading CFD shares

  • Detailed analysis of all the attributes of shares and their explanation

  • Detailed instructions for trading CFD shares

  • BONUS: An overview of the different sectors of the stock market

 

63.21 % of retail investors lose their capital when trading CFDs with this provider.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63.21 % of retail investors lose their capital when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.